BANK OF AMERICA CORP /DE/ - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 134 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0
-100.0%
1,445
-95.7%
0.00%
Q3 2018$15,000
-75.0%
33,530
-72.0%
0.00%
Q2 2018$60,000
-83.3%
119,711
-22.3%
0.00%
Q1 2018$359,000
+16.6%
154,116
+41.6%
0.00%
Q4 2017$308,000
-18.5%
108,820
-17.6%
0.00%
Q3 2017$378,000
+47.7%
132,006
+27.1%
0.00%
Q2 2017$256,000
-47.1%
103,833
-22.6%
0.00%
Q1 2017$484,000
+10.0%
134,133
+7.9%
0.00%
Q4 2016$440,000
+20.5%
124,268
+37.2%
0.00%
Q3 2016$365,000
-32.2%
90,579
-26.1%
0.00%
Q2 2016$538,000
-52.0%
122,534
-58.7%
0.00%
Q1 2016$1,122,000
-43.0%
296,794
+136.3%
0.00%
Q4 2015$1,969,000
+14.5%
125,591
-23.1%
0.00%
Q3 2015$1,720,000
-48.7%
163,303
+22.9%
0.00%
-100.0%
Q2 2015$3,350,000
+20.3%
132,837
+33.0%
0.00%0.0%
Q1 2015$2,784,000
+42.5%
99,877
-6.7%
0.00%0.0%
Q4 2014$1,954,000
+44.7%
107,055
+2.8%
0.00%
Q3 2014$1,350,000
+12.8%
104,176
+41.9%
0.00%
Q2 2014$1,197,000
-11.0%
73,394
-3.6%
0.00%
Q1 2014$1,345,000
-18.0%
76,105
+12.2%
0.00%
-100.0%
Q4 2013$1,641,000
-16.5%
67,811
+22.2%
0.00%0.0%
Q3 2013$1,966,000
+854.4%
55,506
+320.2%
0.00%
Q2 2013$206,00013,2100.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2017
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders